SHARON BARBARI
CIK 1240499 · EVP, Finance & CFO · last filed 2025-12-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.83M
Companies
9
Total Filings
48
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | Director | — | $0.65 | — | $0 | 6 | 2025-12-15 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 974 | $1.51 | $1.5K | $0 | 4 | 2023-06-09 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | 75,000 | — | — | $0 | 4 | 2020-08-21 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Director | — | — | — | $0 | 1 | 2019-05-20 |
| Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Director | 43,417 | — | — | $0 | 6 | 2018-03-02 |
| CYTK | EVP, Finance & CFO | 40,323 | $70.15 | $2.83M | $0 | 15 | 2017-03-02 |
| Sonoma Pharmaceuticals, Inc. (OCLSW) Delisted | Director | 6,244 | — | — | $0 | 1 | 2016-11-30 |
| Sonoma Pharmaceuticals, Inc. (OCLS) Delisted | Director | 5,209 | — | — | $0 | 4 | 2016-08-30 |
| Sonoma Pharmaceuticals, Inc. (OCLS.W) Delisted | Director | 4,356 | — | — | $0 | 5 | 2016-03-02 |
Recent Filings · Page 2 of 5
48 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-21 | VYNE Therapeutics Inc. (MNLO) Delisted | Exer (M) | +75,000 | $111.0K | EDGAR |
| 2020-08-05 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +26,786 | $0 | EDGAR |
| 2020-03-23 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-11 | — | Disp (D) | — | $0 | |
| 2020-03-11 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-20 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-02 | Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Grant (A) | +1,424 | $0 | EDGAR |
| 2018-01-03 | Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Grant (A) | +17,211 | $0 | EDGAR |
| 2017-12-01 | Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Grant (A) | +13,944 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.